AgaMatrix, Inc. And WaveForm Technologies, Inc. Complete $56 Million Capital Raise
Summary
"The completion of this transaction with our new partners at Perceptive Advisors propels our commercial efforts forward and provides the resources necessary for continued development of world-class CGM technologies for diabetes care," said John Alberico, President and CEO of AgaMatrix Holdings LLC. "We believe with this capital raise we have the resources to meet the challenges of the ever expanding CGM market and to support the development of WaveForms next generation continuous glucose sensing products. " "There is great opportunity for our innovative sensor technology to capture significant market share through increased investment in production equipment, research and development, and operational resources afforded by the latest financing," said Jackson McAdam, CFO of AgaMatrix Holdings LLC. AgaMatrix Inc. owns and operates manufacturing and engineering facilities in Salem, NH USA and in Guangdong Province, China. WaveForms products under development include its innovative continuous glucose monitoring technology, which is currently undergoing human clinical trials, and related firmware, software and data storage platforms.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
